Mineralys Therapeutics Inc. (MLYS) NASDAQ
$12.34 (0.67) (-5.15%)
Market Cap: $645.70M
As of 04/15/24 04:00 PM EDT. Market closed.
Mineralys Therapeutics Inc. (MLYS)
NASDAQ
$12.34
(0.67) (-5.15%)
Market Cap: $645.70M
As of 04/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
at mineralys therapeutics we aim to redefine hypertension diagnosis, management and treatment. we are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of ... read more
at mineralys therapeutics we aim to redefine hypertension diagnosis, management and treatment. we are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
12
URL
Address
.
PRICE CHART FOR MINERALYS THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$12.79
Previous Close
$13.01
Days Range
$12.32 - $12.97
52 week range
$5.85 - $17.70
Volume
46,275
Avg. Volume (30 days)
125,415
Market Cap
$645.70M
Dividend Yield
-
P/E
-
Shares Outstanding
49,631,159
Open
$12.79
Previous Close
$13.01
Days Range
$12.32 - $12.97
52 week range
$5.85 - $17.70
Volume
46,275
Avg. Volume (30 days)
125,415
Market Cap
$645.70M
Dividend Yield
-
P/E
-
Shares Outstanding
49,631,159
FINANCIAL STATEMENTS FOR MINERALYS THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR MINERALYS THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Rodman David Malcom | Chief Medical Officer | Apr 12, 2024 | Option Exercise | $1.08 | 6,349 | 6,857 | 66,997 | Apr 15, 2024, 04:24 PM |
| Rodman David Malcom | Chief Medical Officer | Apr 11, 2024 | Option Exercise | $0.54 | 5,017 | 2,709 | 60,648 | Apr 15, 2024, 04:24 PM |
| Rodman David Malcom | Chief Medical Officer | Mar 11, 2024 | Option Exercise | $0.54 | 5,017 | 2,709 | 49,283 | Mar 13, 2024, 05:35 PM |
| Rodman David Malcom | Chief Medical Officer | Mar 12, 2024 | Option Exercise | $1.08 | 6,348 | 6,856 | 55,631 | Mar 13, 2024, 05:35 PM |
| AKKARAJU SRINIVAS | Director | Feb 12, 2024 | Option Exercise | $13.50 | 555,555 | 7,499,993 | 5,074,916 | Feb 14, 2024, 09:07 PM |
| Samsara BioCapital GP, LLC | 10% Owner | Feb 12, 2024 | Buy | $13.50 | 555,555 | 7,499,993 | 5,074,916 | Feb 14, 2024, 09:06 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Feb 12, 2024 | Option Exercise | $13.50 | 1,672,508 | 22,578,858 | 2,983,755 | Feb 14, 2024, 07:49 PM |
| Rodman David Malcom | Chief Medical Officer | Feb 12, 2024 | Option Exercise | $0.84 | 11,366 | 9,566 | 44,266 | Feb 13, 2024, 04:08 PM |
| Rodman David Malcom | Chief Medical Officer | Jan 12, 2024 | Option Exercise | $1.08 | 6,348 | 6,856 | 32,900 | Jan 12, 2024, 04:01 PM |
| Rodman David Malcom | Chief Medical Officer | Jan 11, 2024 | Option Exercise | $0.54 | 5,017 | 2,709 | 26,552 | Jan 12, 2024, 04:01 PM |
| Rodman David Malcom | Chief Medical Officer | Dec 11, 2023 | Option Exercise | $0.54 | 5,018 | 2,710 | 20,069 | Dec 12, 2023, 05:08 PM |
| Congleton Jon | Chief Executive Officer | Nov 22, 2023 | Buy | $5.97 | 4,250 | 25,356 | 1,049,068 | Nov 27, 2023, 04:01 PM |
| Rodman David Malcom | Chief Medical Officer | Nov 13, 2023 | Option Exercise | $0.54 | 5,017 | 2,709 | 15,051 | Nov 14, 2023, 06:18 PM |
| Rodman David Malcom | Chief Medical Officer | Nov 03, 2023 | Option Exercise | $0.54 | 10,034 | 5,418 | 10,034 | Nov 07, 2023, 05:15 PM |
| Congleton Jon | Chief Executive Officer | Sep 06, 2023 | Buy | $12.08 | 2,250 | 27,180 | 1,044,818 | Sep 08, 2023, 08:49 AM |
| Congleton Jon | Chief Executive Officer | Aug 17, 2023 | Buy | $12.10 | 2,250 | 27,225 | 1,042,568 | Aug 21, 2023, 04:03 PM |
| Rodman David Malcom | Chief Medical Officer | Aug 11, 2023 | Option Exercise | $0.80 | 157,091 | 125,967 | 80,909 | Aug 11, 2023, 07:11 PM |
| Rodman David Malcom | Chief Medical Officer | Aug 10, 2023 | Option Exercise | $0.54 | 74,625 | 40,298 | 74,625 | Aug 11, 2023, 07:11 PM |
| Rodman David Malcom | Chief Medical Officer | Aug 11, 2023 | Sale | $12.81 | 157,091 | 2,012,336 | 0 | Aug 11, 2023, 07:11 PM |
| Rodman David Malcom | Chief Medical Officer | Aug 10, 2023 | Sale | $13.16 | 74,625 | 982,065 | 0 | Aug 11, 2023, 07:11 PM |
| Congleton Jon | Chief Executive Officer | Aug 11, 2023 | Buy | $12.89 | 2,000 | 25,780 | 1,040,318 | Aug 11, 2023, 07:11 PM |
| HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | Feb 14, 2023 | Buy | $16.00 | 312,500 | 5,000,000 | 3,218,106 | Feb 16, 2023, 09:00 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Feb 14, 2023 | Buy | $16.00 | 1,250,000 | 20,000,000 | 1,867,229 | Feb 16, 2023, 05:04 PM |
| Levy Adam Scott | CFO, Chief Bus. Off. and Secy. | Feb 14, 2023 | Buy | $16.00 | 6,250 | 100,000 | 350,811 | Feb 16, 2023, 04:54 PM |
| AKKARAJU SRINIVAS | Director | Feb 14, 2023 | Buy | $16.00 | 937,500 | 15,000,000 | 4,519,361 | Feb 16, 2023, 04:54 PM |
| Slingsby Brian Taylor | Director | Feb 14, 2023 | Buy | $16.00 | 250,000 | 4,000,000 | 9,194,579 | Feb 16, 2023, 04:54 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Rodman David Malcom | Chief Medical Officer | 04/12/2024 | 6,857 |
| Rodman David Malcom | Chief Medical Officer | 04/11/2024 | 2,709 |
| Rodman David Malcom | Chief Medical Officer | 03/11/2024 | 2,709 |
| Rodman David Malcom | Chief Medical Officer | 03/12/2024 | 6,856 |
| AKKARAJU SRINIVAS | Director | 02/12/2024 | 7,499,993 |
| Samsara BioCapital GP, LLC | 10% Owner | 02/12/2024 | 7,499,993 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 02/12/2024 | 22,578,858 |
| Rodman David Malcom | Chief Medical Officer | 02/12/2024 | 9,566 |
| Rodman David Malcom | Chief Medical Officer | 01/12/2024 | 6,856 |
| Rodman David Malcom | Chief Medical Officer | 01/11/2024 | 2,709 |
| Rodman David Malcom | Chief Medical Officer | 12/11/2023 | 2,710 |
| Congleton Jon | Chief Executive Officer | 11/22/2023 | 25,356 |
| Rodman David Malcom | Chief Medical Officer | 11/13/2023 | 2,709 |
| Rodman David Malcom | Chief Medical Officer | 11/03/2023 | 5,418 |
| Congleton Jon | Chief Executive Officer | 09/06/2023 | 27,180 |
| Congleton Jon | Chief Executive Officer | 08/17/2023 | 27,225 |
| Rodman David Malcom | Chief Medical Officer | 08/11/2023 | 125,967 |
| Rodman David Malcom | Chief Medical Officer | 08/10/2023 | 40,298 |
| Rodman David Malcom | Chief Medical Officer | 08/11/2023 | 2,012,336 |
| Rodman David Malcom | Chief Medical Officer | 08/10/2023 | 982,065 |
| Congleton Jon | Chief Executive Officer | 08/11/2023 | 25,780 |
| HBM Healthcare Investments (Cayman) Ltd. | 10% Owner | 02/14/2023 | 5,000,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 02/14/2023 | 20,000,000 |
| Levy Adam Scott | CFO, Chief Bus. Off. and Secy. | 02/14/2023 | 100,000 |
| AKKARAJU SRINIVAS | Director | 02/14/2023 | 15,000,000 |
| Slingsby Brian Taylor | Director | 02/14/2023 | 4,000,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN MINERALYS THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 4,949,307 | 1.15% | 55.71% | Other |
| BLACKROCK INC. | 1,394,774 | 0.00031% | 55.83% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 376,322 | 0.00034% | 25.46% | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 206,265 | 0.02% | -58.86% | Growth |
| UBS OCONNOR LLC | 186,168 | 0.12% | New | Value |
| ALPS ADVISORS INC | 26,675 | 0.0018% | -11.52% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 25,500 | 0.00034% | -73.35% | Other |
CHANGE IN SHARES OUTSTANDING FOR MINERALYS THERAPEUTICS INC
STOCK BUYBACKS FOR MINERALYS THERAPEUTICS INC
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.51%
1Q
06/30/2023
0.96%
2Q
BUYBACK ANNOUNCEMENT(S) FOR MINERALYS THERAPEUTICS INC
LOADING...